MedTrace Logo

The KaHOLO Project: Preventing Cardiovascular Disease in Native Hawaiians

NCT02620709 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 275

Last updated 2020-03-25

No results posted yet for this study

Summary

This project is a community-engaged, randomized control trial of hula, the indigenous dance form of Native Hawaiians (NH), among 250 NHs with hypertension living in Hawaii and Washington State. Investigators will compare the effects of a 6-month intervention, called the KaHOLO Program, delivered by trained peer educators to a wait-list control condition on blood pressure and 10-year cardiovascular risk. The intervention will be comprised of hula plus hypertension self-care education program. Investigators will also examine the mediating effects of health behaviors, self-regulation, psychosocial, and socio-cultural factors on blood pressure reduction. The ultimate goal is to develop and test a culturally-appropriate, acceptable, and effective intervention that can be delivered and sustained in community settings.

Conditions

Interventions

BEHAVIORAL

Hula intervention

Hula and heart health education

Sponsors & Collaborators

  • I Ola Lahui, Inc.

    collaborator OTHER

  • Ke Ola Mamo

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • Hui No Ke Ola Pono, Inc.

    collaborator OTHER

  • Kula No Na Po'e Hawaii

    collaborator OTHER

  • University of Hawaii

    lead OTHER

Principal Investigators

  • Joseph K Kaholokula, PhD · University of Hawaii

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-03-31
Completion
2021-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02620709 on ClinicalTrials.gov